scholarly journals COGNITIVE IMPAIRMENT DETECTION IN ADULT THALASSEMIA PATIENT USING MOCA-INA

2021 ◽  
Vol 7 (1) ◽  
pp. 24-29
Author(s):  
Chandra Calista Wardoyo ◽  
Uni Gamayani ◽  
Anam Ong ◽  
Ahmad Rizal ◽  
Yusuf Wibisono ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Healthy Subjects ◽  
Screening Tools ◽  
Case Group ◽  
Control Groups ◽  
Thalassemia Patient ◽  
Cognitive Domains ◽  
A Value ◽  
Healthy Control ◽  
And Control

Background: Cognitive impairment in thalassemia patients are prevalent, therefore early detection of cognitive impairment in adult thalassemia patients is crucial for prevention. Montreal Cognitive Assessment (MoCA) is a public domain cognition screening tools that covers all cognitive domains in detecting mild cognitive impairments. Objective: To compare cognitive function between adult thalassemia patients and healty control by using Indonesia version of MoCA test (MoCA-Ina) Methods: This prospective observational analytic with case control study, compared the total scores and scores of each domain of cognition between adult thalassemia patients and healthy subjects at the Medical Hematology Oncology Clinic of Dr. Hasan Sadikin General Hospital, Bandung, Indonesia using MoCA-Ina from August to October 2018. Results: A total of 32 thalassemia subjects and 50 healthy subjects were conducted. A total of 16(50%) subjects in the case group had a value of MoCA-Ina <26, while only 1(2%) healthy control had a value of MoCA-Ina <26. The median total MoCA-Ina score in case and control groups were 25.5 and 27.50 (p <0.001). The median score of memory domains, executive functions and visuospatial of the case and control groups were 3 versus 4 (p <0.001), 3 versus 3.5 (p <0.001) and 3.53 ± 0.671 versus 3.88 ± 0.385 (p <0.003), respectively. Conclusion: Adults thalassemia patients have lower score in total MoCA-Ina, domains of memory, executive function and visuospatial score compared to healthy control.

Survey of the status of iron and sclerostin in major Thalassemia Patients

2018 ◽  
Author(s):  
Leila Moinzadeh ◽  
Mohammad Reza Keramati ◽  
Mohammad Taha Jalali ◽  
Bejan Keikhaei ◽  
Najmaldin Saki ◽  
...  
Keyword(s):  
Bone Loss ◽  
Iron Overload ◽  
Beta Thalassemia ◽  
Case Group ◽  
Elisa Method ◽  
Control Groups ◽  
The World ◽  
The Status ◽  
Healthy Control ◽  
And Control

Background and Aims: Thalassemia is one the most prevalent genetic anemia in the world; homozygote patients usually suffer from severe disturbances. Osteopenia and osteoporosis are of various types of thalassemia complications which are increase in rate in patients with iron overload conditions. Sclerostin is a protein which enhances bone loss by inhibiting osteoblasts. The aim of this study was to measure sclerostin protein and its association with iron overload in major thalassemia patients. Materials and Methods: Forty patients with major beta-Thalassemia and 40 healthy control individuals were includedin the study; Sclerostin protein and ferritin were evaluated using ELISA method. Results: Mean sclerostin protein was 100.7 pg/ml, in the case group; it was 143.1 pg/ml in the control group.There was a significant differences between sclerostin protein in case and control groups (p= 0.015). The association of sclerostin and ferritin was not significant in the case group (p= 0.7), while  it was meaningful in the control individuals (p= 0.037). Conclusion: Our findings suggest that sclerostin protein can play an important role in the pathogenesis of osteoporosis.

scholarly journals Cognitive impairments in sporadic cerebral small vessel disease (SVD): a systematic review and meta-analysis of cohorts with stroke, dementia and non-clinical presentations of SVD

2020 ◽  
Author(s):  
Olivia KL Hamilton ◽  
Ellen V Backhouse ◽  
Esther Janssen ◽  
Angela CC Jochems ◽  
Caragh Maher ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Executive Function ◽  
Cognitive Impairments ◽  
Clinical Manifestations ◽  
Cognitive Test ◽  
Visuospatial Ability ◽  
Control Groups ◽  
Cognitive Domains ◽  
Clinical Presentations ◽  
And Control

AbstractBackgroundCognitive impairment is a key clinical feature of cerebral small vessel disease (SVD), but the full range of SVD-related cognitive impairments is unclear, and little is known about how they might vary across clinical and non-clinical manifestations of SVD.MethodsIn systematic searches of OVID MEDLINE, Embase, and PsychINFO from 1st January 1985 to 6th October 2019, we identified studies reporting cognitive test results for study participants with SVD and control participants without SVD. Using standardised group-level cognitive test data, we performed random effects meta-analyses in seven cognitive domains to test whether cognitive test scores differed between SVD and control groups. We conducted meta-regression analyses to test whether differences in age, education, or vascular risk factors between SVD and control groups, or whether different clinical manifestations of SVD (e.g. stroke, cognitive impairment, or non-clinical presentations) accounted for cognitive effect sizes.FindingsOf 8562 studies identified, we included 69 studies from six continents, published in four languages. These studies included 3229 participants with SVD and 3679 controls. Meta-analyses demonstrated that on average, control groups outperformed SVD cohorts on cognitive tests in all cognitive domains examined: executive function (estimate: -0.928; 95%CI: -1.08, -0.78); processing speed (-0.885; -1.17, -0.60); delayed memory (-0.898; -1.10, -0.69); language (-0.808; -1.01, -0.60); visuospatial ability (-0.720; -0.96, -0.48); reasoning (-0.634; -0.93, -0.34); and attention (-0.622; -0.94, -0.31; all p≤0.001). Meta-regression analyses suggested that differences in years of education between SVD and control groups may account for a proportion of the differences in performance on tests of executive function, visuospatial ability and language, and that cohorts with cognitive impairments performed more poorly on tests of executive function, delayed memory and visuospatial ability than cohorts with stroke or non-clinical presentations of SVD.InterpretationParticipants with SVD demonstrated poorer cognitive performance relative to control groups in all cognitive domains we examined. This effect was present for all presentations of SVD, reinforcing the need to test a range of cognitive domains in both clinical and research settings. Lower levels of education in SVD versus control participants may contribute to these effects, highlighting the need to account for educational level in the assessment of SVD-related cognitive impairment.FundingNone.

scholarly journals Pengaruh Terapi AIUEO terhadap Kemampuan Bicara Pasien Stroke yang Mengalami Afasia Motorik

2019 ◽  
Vol 1 (2) ◽  
pp. 226-235
Author(s):  
Afnijar Wahyu ◽  
Liza Wati ◽  
Murad Fajri
Keyword(s):  
Wilcoxon Test ◽  
Control Group ◽  
Stroke Patients ◽  
Control Groups ◽  
Control Group Design ◽  
Treatment Groups ◽  
Group Design ◽  
Motor Aphasia ◽  
A Value ◽  
And Control

The purpose of this study was to determine the effect of AIUEO therapy on the speech ability of stroke patients who have motor aphasia in Raja Ahmad Thabib Hospital Tanjungpinang. The research design used was quasi experiment with the Nonequivalent Control Group Design approach to 9 respondents who were divided into 9 treatment groups and 9 control groups. The results showed that there were significant differences in the functional ability of communication between the control and treatment groups with a value of p <0.05 (p = 0.007 at a = 0.05) using the Wilcoxon Test statistical test. Conclusion, the influence of AIUEO therapy on the speech ability of stroke patients with motor aphasia in the treatment and control groups at Ahmad Thabib Hospital Tanjungpinang.   Keywords: Speech Ability, Motor Aphasia Stroke, AIUEO Therapy

A Novel Polymorphic Purine Complex at the Upstream Region of the Human Caveolin-1 Gene and Risk of Alzheimer’s Disease

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Ohadi ◽  
Y. Heshmati ◽  
A. Mirabzadeh ◽  
H.R. Khorram Khorshid ◽  
K. Kamali
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Late Onset ◽  
Upstream Region ◽  
Case Group ◽  
Control Groups ◽  
Gene Encoding ◽  
Aberrant Expression ◽  
Caveolin 1 ◽  
And Control

Crucial interaction of caveolin-1 (CAV1) with beta- and gamma-secretases, and aberrant expression of the gene encoding this protein in Alzheimer's disease (AD) support a role for CAV1 in the pathophysiology of this disease.We report a novel polymorphic purine complex stretching ~150 bp of genomic DNA at the 1.5 kb upstream region of the human CAV1 gene, alleles and genotypes of which are associated with sporadic late-onset AD. Extra-short alleles were observed in the case group that were absent in the control subjects. Increased homozygosity for haplotypes was also observed at this region in the Alzheimer's cases, for those alleles and allele lengths shared by the case and control groups [(c2=30.75, df=1, p< .000, OR=4.54, CI 95% (2.56-8.3)]. This region contains GGAA and GAAA motifs, the consensus binding sites for the Ets and IRF family transcription factors, respectively, and is highly conserved in distantly-related non-human primates in respect with location and motif sequence. The effect of this complex sequence on the expression of CAV1, and the related mechanisms in the pathophysiology of AD remain to be clarified.

The effect of lavandula angustifolia in the treatment of depression

2011 ◽  
Vol 26 (S2) ◽  
pp. 624-624 ◽  
Author(s):  
N. Parvin ◽  
S. Farzaneh ◽  
M. Nikfarjam ◽  
N. Shahinfard ◽  
N. Asarzadegan
Keyword(s):  
Depression Score ◽  
Control Group ◽  
Case Group ◽  
Double Blind Study ◽  
Control Groups ◽  
Chi Square ◽  
Double Blind ◽  
Treatment Of Depression ◽  
Severity Of Depression ◽  
And Control

Background and aimMedical plants have been used for centuries as a medicinal agent in treatment of depression and anxiety. The purpose of this study was to explore the effects of the lavendula officinalis on depression in patients using citalopram.MethodsThis clinical trial study was performed in Hajar hospital, Shahrekord, Iran. In this study eighty patients randomly allocated into two groups (40 patients in each group). Patients who complained from depression were studied during a two-month double-blind study. In control group, patients were given 20 mg citalopram twice daily plus placebo and case group were treated with 5 g arial part of dried Lavendula officinalis and citaloperam (20 mg, twice per day). After 4 and 8 weeks, patients were followed for evaluations of their depression and complications. Depression severity was scored using standard Hamilton’s depression questionnaire. Data were analyzed using Chi square and Paired-t test.ResultsAfter 1 month treatment, mean depression score in case and control groups were 15.2 ± 3.6 and 17.5 ± 3.5, respectively (P < 0.05). After 2 months the mean score of depression in case and control groups was 14.8 ± 4 and 16.8 ± 4.6, respectively (P < 0.01). The most common side effects in two groups were confusion and dry mouth, which were not significantly different between two groups.ConclusionLavendula officinalis has a positive effect on depressed patients and may be useful to decrease the severity of depression in patients using other antidepressants.

scholarly journals Use of Immunohistochemistry Techniques in Patients Exposed to Sulphur Mustard Gas

2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Mostafa Ghanei ◽  
Marco Chilosi ◽  
Hassan Mohammad Hosseini Akbari ◽  
Rouzbeh Motiei-Langroudi ◽  
Ali Amini Harandi ◽  
...  
Keyword(s):  
Open Lung Biopsy ◽  
Control Group ◽  
Case Group ◽  
Mustard Gas ◽  
Control Groups ◽  
Sulphur Mustard ◽  
Pathologic Diagnosis ◽  
The Mean ◽  
And Control ◽  
Number Of Cells

We performed a pathologic study with further using an immunohistochemical technique (using anti-p63 and anti-CK5) on tissues obtained by open lung biopsy from 18 patients with previous exposure to sulphur mustard (SM) as case group and 8 unexposed patients (control group). The most frequent pathologic diagnosis was constrictive bronchiolitis (44.4%), followed by respiratory (22.2%) and chronic cellular bronchiolitis (16.7%) in the case group, and hypersensitivity bronchiolitis (50%) in the control group. The pathologic diagnoses were significantly different in the case and control groups (P=0.042). In slides stained by anti-p63 and anti-CK5, the percent of stained cells and the mean number of epithelial cells were lower in the case group in comparison to the control group. This difference was significant for the mean number of cells stained by anti-CK5 (P=0.042). Furthermore, there was a significant correlation between pathologic diagnosis and total number of cells and mean number of cells stained with anti-p63 and anti-CK5 (P  value = 0.002, <0.001, 0.044). These results suggest that constrictive bronchiolitis may be the major pathologic consequence of exposure to SM. Moreover, decrease of p63 in respiratory tissues affected by SM may suggest the lack of regenerative capacity in these patients.

scholarly journals The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Karim Y. A. Shaheen ◽  
Abeer I. Abdel-Mageed ◽  
Eslam Safwat ◽  
Ashraf M. AlBreedy
Keyword(s):  
Healthy Subjects ◽  
Operating Characteristic ◽  
Diagnostic Marker ◽  
Characteristic Curve ◽  
Area Under The Curve ◽  
Tumor Diameter ◽  
Control Groups ◽  
Tumor Number ◽  
Healthy Control ◽  
Operating Characteristic Curve

Background and Aim. Identification of sensitive biomarkers to improve early diagnosis of HCC is needed. We aimed to evaluate serum midkine (MDK) as a biomarker for HCC diagnosis.Patients and Methods. 40 HCCs, 30 liver cirrhosis patients, and 30 healthy subjects were enrolled. Serum MDK using ELISA was measured in all included subjects.Results. Serum MDK was significantly elevated in HCC group compared to cirrhotic and healthy control groups (0.625 versus 0.15 and 0.125 ng/mL), respectively. No significant association was found between MDK and either BCLC stage, tumor diameter, tumor number, or AFP level. Receiver operating characteristic curve showed that best cutoff for MDK and AFP was 0.387 and 88.5 ng/mL, respectively. Area under the curve of MDK was significantly larger than that of AFP (0.941 versus 0.671). The sensitivity of MDK at 0.387 ng/mL for HCC diagnosis was significantly higher than that of AFP at cutoffs 20, 88.5, and 200 ng/mL (92.5 versus 62.5, 40, and 25%), respectively. Sensitivity of MDK reached 93.3% in patients with AFP <20 ng/mL. Moreover, MDK at 0.387 ng/mL had significant better sensitivity than AFP at 20 ng/mL in distinguishing HCC from BCLC 0/A (90 versus 40%).Conclusion. Serum MDK might be a potential diagnostic marker for HCC particularity in its early stages.

scholarly journals Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinsons disease

2021 ◽  
Author(s):  
Pedro Alexandre Pereira ◽  
Drupad Trivedi ◽  
Justin Silverman ◽  
Ilhan Duru ◽  
Lars K Paulin ◽  
...  
Keyword(s):  
Energy Metabolism ◽  
Bacterial Community ◽  
Bacterial Community Composition ◽  
Control Groups ◽  
Parkinsons Disease ◽  
Clinical Variables ◽  
Metabolite Profiles ◽  
Healthy Control ◽  
And Control ◽  
Altered Lipid

We aimed to investigate the link between serum metabolites, gut bacterial community composition, and clinical variables in Parkinsons disease (PD) and healthy control subjects (HC). 139 metabolite features were found to be differentially abundant between the PD and Control groups. No associations were found between metabolite features and within-PD clinical variables. The results suggest alterations in serum metabolite profiles in PD, and the results of correlation analysis between metabolite features and microbiota suggest that several bacterial taxa are associated with altered lipid and energy metabolism in PD.

scholarly journals X-ray spectral microanalysis of the sternum in patients with congenital pectus excavatum

2019 ◽  
Vol 100 (5) ◽  
pp. 757-761
Author(s):  
V B Shamik
Keyword(s):  
Healthy Subjects ◽  
Pectus Excavatum ◽  
Atomic Orbital ◽  
Healthy Children ◽  
Control Groups ◽  
Important Indicator ◽  
X Ray ◽  
Graphic Data ◽  
Mineral Matrix ◽  
And Control

Aim. To study the mineral composition of the sternum in patients with congenital funnel-shaped deformations of the chest. Methods. X-ray spectral microanalysis of the sternum was performed in 10 patients with pectus excavatum aged 1417 years (30 zones) on a scanning electron microscope with an accelerating voltage of 25 kV. The results of the sternum examination of 3 patients aged 1416 years (10 zones) operated on for other diseases were used as the control. Results. Graphic images of mineralization of each investigated zone of the sternum were obtained. As a result of processing the graphic data, the IBAS-200 system obtained average atomic orbital values, weight and atomic percent, net and background intensities and their ratios, intensity errors of the elements-constituents of mineral matrix of the sternum. The structures of the sternum in the main and control groups did not differ. The predominant elements are oxygen (O), phosphorus (P) and calcium (Ca). Their net intensity in patients and in healthy subjects of the corresponding age was 101.162.78 and 99.231.97 (р 0.001), respectively; 402.382.23 and 421.281.99 (р 0,001); 586.412.37 and 601.321.99 (р 0.001). Net intensity of phosphorus and calcium in healthy children was higher by 2.54.5%, and that of oxygen was lower by 1.9%. An important indicator is the ratio of the net and background intensities of the elements. Conclusion. Net intensity of phosphorus and calcium in healthy children was higher, in the pathogenesis of the deformation of the chest, the sternum changes its shape secondarily.

Sign in / Sign up

Export Citation Format

Share Document